Organic compounds -- part of the class 532-570 series – Organic compounds – Chalcogen in the nitrogen containing substituent
Reexamination Certificate
2008-01-29
2008-01-29
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Chalcogen in the nitrogen containing substituent
C544S106000, C544S170000, C544S386000, C544S390000, C540S450000, C540S451000, C540S484000, C540S485000, C546S226000, C514S231200, C514S255030, C514S237500, C514S227500, C514S211010, C514S330000
Reexamination Certificate
active
07323563
ABSTRACT:
A method for the treatment of bacterial infections in humans and non-human mammals, which comprises inhibiting bacterial growth by administering to a subject an antibacterially effective dose of a compound of formula (I) or a pharmaceutically or veterinarily acceptable salt thereof:
REFERENCES:
patent: 4303662 (1981-12-01), Sprague
patent: 5453438 (1995-09-01), Campion et al.
patent: 5532265 (1996-07-01), Gijbels et al.
patent: 5691382 (1997-11-01), Crimmin et al.
patent: 5962529 (1999-10-01), Miller et al.
patent: 6281245 (2001-08-01), Patel et al.
patent: 6441042 (2002-08-01), Hunter et al.
patent: 6787522 (2004-09-01), Hunter et al.
patent: 1028921 (1966-05-01), None
patent: 3-53891 (1991-03-01), None
patent: 3-157372 (1991-07-01), None
patent: WO 92/22523 (1992-12-01), None
patent: WO 94 10990 (1994-05-01), None
patent: WO 95/06031 (1995-03-01), None
patent: WO 96/33165 (1996-10-01), None
patent: WO 98/24474 (1998-06-01), None
Devlin et al, J. C. S. Perkin I, vol. 9, pp. 848-851, 1975.
“Matlystatins, New Inhibitors of Type IV Collagenases From Actinomadura Atramentaria II Biological Activities” Kazuhiko Tanzawa, et al. (1992) The Journal of Antibiotics, vol. 45, No. 11, pp. 1733-1737.
Inhibition of Proteases in Pseudomonas Otitis Media In Chinchillas, Cheryl S. Cotter, et al., Otolaryngology—Head and Neck Surgery, (1996), vol. 115, No. 4, pp. 342-351.
“Antibiotic Actinonin I to VIII”, J. Chem, Soc. Perkin Trans 1, vol. 9, 1975, pp. 819-860.
“Galardin™ Antiinflammatory Protease Inhibitor”, Richard E. Galardy, Drugs of the Future, 1993, 18(12): 109-111.
Beckett Paul Raymond
Clements John Martin
Hunter Michael George
Spavold Zoe Marie
Whittaker Mark
Banner & Witcoff , Ltd.
British Biotech Pharmaceuticals Ltd.
Kumar Shailendra
LandOfFree
Hydroxamic acid derivatives as antibacterials does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxamic acid derivatives as antibacterials, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid derivatives as antibacterials will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2780424